Francis Vacherot
Overview
Explore the profile of Francis Vacherot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
954
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phan H, Cavanagh R, Jacob P, Destouches D, Vacherot F, Brugnoli B, et al.
Polymers (Basel)
. 2023 Jul;
15(14).
PMID: 37514459
Polymersomes are an exciting modality for drug delivery due to their structural similarity to biological cells and their ability to encapsulate both hydrophilic and hydrophobic drugs. In this regard, the...
2.
Groeneveld C, Sanchez-Quiles V, Dufour F, Shi M, Dingli F, Nicolle R, et al.
Eur Urol
. 2023 Jun;
85(5):483-494.
PMID: 37380559
Background: Molecular understanding of muscle-invasive (MIBC) and non-muscle-invasive (NMIBC) bladder cancer is currently based primarily on transcriptomic and genomic analyses. Objective: To conduct proteogenomic analyses to gain insights into bladder...
3.
Majidipur A, Morin-Dewaele M, Gaspar Lopes J, Berry F, Fouchet J, Bartier S, et al.
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36834705
In early 2020, the novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, and rapidly propagated worldwide causing a global health emergency. SARS-CoV-2 binds to the...
4.
Blanc C, Moktefi A, Jolly A, De La Grange P, Gay D, Nicolaiew N, et al.
Br J Cancer
. 2022 Dec;
128(5):918-927.
PMID: 36550208
Background: Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate cancer (PCa) that has become a major challenge in clinics. Understanding the neuroendocrine differentiation (NED) process at the molecular...
5.
Berry F, Morin-Dewaele M, Majidipur A, Jamet T, Bartier S, Ignjatovic E, et al.
J Extracell Vesicles
. 2022 Oct;
11(10):e12269.
PMID: 36271885
Small Extracellular Vesicles (sEVs) are 50-200 nm in diameter vesicles delimited by a lipid bilayer, formed within the endosomal network or derived from the plasma membrane. They are secreted in...
6.
Firlej V, Soyeux P, Nourieh M, Huet E, Semprez F, Allory Y, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35562881
Prostate cancer (PCa) is the second most frequent cancer and the fifth leading cause of cancer death in men worldwide. If local PCa presents a favorable prognosis, available treatments for...
7.
Almeida A, Gabriel M, Firlej V, Martin-Jaular L, Lejars M, Cipolla R, et al.
J Extracell Vesicles
. 2022 May;
11(5):e12210.
PMID: 35527349
Long noncoding (lnc)RNAs modulate gene expression alongside presenting unexpected source of neoantigens. Despite their immense interest, their ability to be transferred and control adjacent cells is unknown. Extracellular Vesicles (EVs)...
8.
Saldana C, Majidipur A, Beaumont E, Huet E, De La Taille A, Vacherot F, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359692
Prostate cancer (PCa) is the second most frequent cancer and the fifth leading cause of cancer death among men worldwide. At first, advanced PCa is treated by androgen deprivation therapy...
9.
Teinturier R, Luo Y, Decaussin-Petrucci M, Vlaeminck-Guillem V, Vacherot F, Firlej V, et al.
Oncogene
. 2020 Dec;
40(6):1118-1127.
PMID: 33323967
Dysregulated androgen receptor (AR) plays a crucial role in prostate cancer (PCa) development, though further factors involved in its regulation remain to be identified. Recently, paradoxical results were reported on...
10.
Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data
Lamy P, Rebillard X, Vacherot F, De La Taille A
World J Urol
. 2020 Jun;
39(8):3121-3123.
PMID: 32488360
No abstract available.